PharmaBlock Sciences Nanjing Inc
SZSE:300725
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Price:
31.05
CNY
1.64%
Market Closed
Market Cap:
6.2B
CNY
Income Statement
Earnings Waterfall
PharmaBlock Sciences Nanjing Inc
PharmaBlock Sciences Nanjing Inc
|
Revenue
|
1.6B
CNY
|
|
Cost of Revenue
|
-960.2m
CNY
|
|
Gross Profit
|
601.5m
CNY
|
|
Operating Expenses
|
-407.5m
CNY
|
|
Operating Income
|
194m
CNY
|
|
Other Expenses
|
-18.9m
CNY
|
|
Net Income
|
175.1m
CNY
|
Income Statement
PharmaBlock Sciences Nanjing Inc
PharmaBlock Sciences Nanjing Inc
Currency: CNY
Millions
TTM
| Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||
| Revenue |
244
N/A
|
273
+12%
|
319
+17%
|
362
+13%
|
417
+15%
|
478
+15%
|
531
+11%
|
558
+5%
|
603
+8%
|
662
+10%
|
681
+3%
|
831
+22%
|
924
+11%
|
1 022
+11%
|
1 138
+11%
|
1 184
+4%
|
1 200
+1%
|
1 202
+0%
|
1 251
+4%
|
1 315
+5%
|
1 483
+13%
|
1 595
+8%
|
1 642
+3%
|
1 704
+4%
|
1 701
0%
|
1 725
+1%
|
1 719
0%
|
1 626
-5%
|
1 562
-4%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||
| Cost of Revenue |
(89)
|
(105)
|
(131)
|
(156)
|
(188)
|
(207)
|
(233)
|
(244)
|
(276)
|
(323)
|
(354)
|
(451)
|
(506)
|
(556)
|
(619)
|
(624)
|
(628)
|
(633)
|
(658)
|
(702)
|
(799)
|
(879)
|
(917)
|
(976)
|
(998)
|
(1 018)
|
(1 018)
|
(979)
|
(960)
|
|
| Gross Profit |
155
N/A
|
168
+8%
|
189
+12%
|
206
+9%
|
229
+11%
|
271
+19%
|
298
+10%
|
314
+5%
|
328
+4%
|
340
+4%
|
327
-4%
|
380
+16%
|
418
+10%
|
466
+11%
|
519
+11%
|
560
+8%
|
571
+2%
|
569
0%
|
593
+4%
|
613
+3%
|
685
+12%
|
716
+5%
|
725
+1%
|
728
+0%
|
704
-3%
|
707
+1%
|
701
-1%
|
647
-8%
|
601
-7%
|
|
| Operating Income | ||||||||||||||||||||||||||||||
| Operating Expenses |
(86)
|
(90)
|
(102)
|
(108)
|
(119)
|
(127)
|
(138)
|
(149)
|
(156)
|
(178)
|
(185)
|
(213)
|
(222)
|
(254)
|
(273)
|
(269)
|
(292)
|
(301)
|
(306)
|
(357)
|
(404)
|
(437)
|
(467)
|
(486)
|
(470)
|
(449)
|
(453)
|
(429)
|
(407)
|
|
| Selling, General & Administrative |
(83)
|
(60)
|
(99)
|
(106)
|
(102)
|
(82)
|
(91)
|
(90)
|
(89)
|
(102)
|
(113)
|
(129)
|
(146)
|
(156)
|
(167)
|
(163)
|
(171)
|
(172)
|
(184)
|
(211)
|
(240)
|
(242)
|
(268)
|
(271)
|
(265)
|
(257)
|
(259)
|
(252)
|
(249)
|
|
| Research & Development |
0
|
(25)
|
0
|
0
|
(10)
|
(41)
|
(41)
|
(56)
|
(66)
|
(63)
|
(72)
|
(78)
|
(77)
|
(83)
|
(103)
|
(103)
|
(115)
|
(103)
|
(112)
|
(135)
|
(154)
|
(155)
|
(189)
|
(189)
|
(180)
|
(156)
|
(155)
|
(140)
|
(126)
|
|
| Depreciation & Amortization |
0
|
(5)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(38)
|
0
|
0
|
0
|
(38)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(3)
|
(0)
|
(3)
|
(2)
|
(7)
|
6
|
(6)
|
(3)
|
(2)
|
(1)
|
(1)
|
(6)
|
0
|
(0)
|
(2)
|
(3)
|
(6)
|
(2)
|
(10)
|
(10)
|
(10)
|
(1)
|
(9)
|
(26)
|
(25)
|
2
|
(39)
|
(37)
|
(34)
|
|
| Operating Income |
69
N/A
|
78
+13%
|
87
+11%
|
98
+13%
|
110
+12%
|
145
+32%
|
161
+11%
|
166
+3%
|
171
+4%
|
161
-6%
|
142
-12%
|
167
+18%
|
196
+17%
|
212
+8%
|
246
+16%
|
291
+18%
|
280
-4%
|
268
-4%
|
287
+7%
|
256
-11%
|
281
+9%
|
279
-1%
|
259
-7%
|
243
-6%
|
234
-4%
|
258
+10%
|
247
-4%
|
218
-12%
|
194
-11%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||
| Interest Income Expense |
(2)
|
(3)
|
(3)
|
(1)
|
8
|
(2)
|
(6)
|
(5)
|
(3)
|
2
|
15
|
16
|
(1)
|
(18)
|
(8)
|
203
|
219
|
225
|
213
|
8
|
12
|
17
|
9
|
(23)
|
(63)
|
(62)
|
(61)
|
(21)
|
(10)
|
|
| Non-Reccuring Items |
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
(0)
|
(14)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
5
|
3
|
4
|
5
|
5
|
11
|
12
|
12
|
11
|
9
|
9
|
11
|
12
|
11
|
12
|
12
|
12
|
15
|
14
|
15
|
24
|
31
|
27
|
50
|
40
|
40
|
36
|
14
|
15
|
|
| Pre-Tax Income |
72
N/A
|
77
+6%
|
88
+14%
|
102
+17%
|
123
+20%
|
154
+25%
|
167
+8%
|
173
+3%
|
180
+4%
|
172
-4%
|
166
-4%
|
194
+17%
|
206
+6%
|
205
-1%
|
249
+22%
|
506
+103%
|
511
+1%
|
508
-1%
|
514
+1%
|
280
-46%
|
317
+13%
|
323
+2%
|
294
-9%
|
269
-8%
|
211
-22%
|
221
+5%
|
223
+1%
|
211
-5%
|
199
-6%
|
|
| Net Income | ||||||||||||||||||||||||||||||
| Tax Provision |
(10)
|
(9)
|
(11)
|
(12)
|
(13)
|
(20)
|
(20)
|
(23)
|
(23)
|
(20)
|
(19)
|
(24)
|
(29)
|
(20)
|
(24)
|
(23)
|
(18)
|
(4)
|
(6)
|
3
|
(3)
|
3
|
15
|
6
|
8
|
(24)
|
(34)
|
(29)
|
(24)
|
|
| Income from Continuing Operations |
62
|
68
|
77
|
90
|
110
|
135
|
147
|
150
|
157
|
152
|
147
|
170
|
177
|
184
|
226
|
483
|
493
|
504
|
508
|
283
|
314
|
326
|
309
|
275
|
219
|
197
|
189
|
182
|
175
|
|
| Income to Minority Interest |
1
|
(1)
|
(2)
|
(2)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(9)
|
(17)
|
(21)
|
(24)
|
(20)
|
(12)
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
62
N/A
|
67
+8%
|
75
+11%
|
89
+19%
|
109
+23%
|
133
+23%
|
147
+10%
|
150
+2%
|
157
+5%
|
152
-3%
|
147
-3%
|
170
+16%
|
177
+4%
|
184
+4%
|
226
+23%
|
478
+112%
|
484
+1%
|
487
+0%
|
488
+0%
|
258
-47%
|
294
+14%
|
314
+7%
|
301
-4%
|
275
-9%
|
219
-20%
|
197
-10%
|
189
-4%
|
182
-4%
|
175
-4%
|
|
| EPS (Diluted) |
0.44
N/A
|
0.47
+7%
|
0.4
-15%
|
0.47
+18%
|
0.59
+26%
|
0.72
+22%
|
0.79
+10%
|
0.8
+1%
|
0.84
+5%
|
0.82
-2%
|
0.78
-5%
|
0.91
+17%
|
0.94
+3%
|
0.99
+5%
|
1.2
+21%
|
2.29
+91%
|
2.42
+6%
|
2.44
+1%
|
2.46
+1%
|
1.3
-47%
|
1.48
+14%
|
1.57
+6%
|
1.51
-4%
|
1.38
-9%
|
1.09
-21%
|
0.98
-10%
|
0.93
-5%
|
0.92
-1%
|
0.87
-5%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
